Astellas Pharma (ALPMY) Short Interest Ratio & Short Volume $10.07 0.00 (0.00%) (As of 11/20/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest Astellas Pharma Short Interest DataAstellas Pharma (ALPMY) has a short interest of 9,100 shares. This marks a -79.82% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 232,249 shares to cover all short positions.Current Short Interest9,100 sharesPrevious Short Interest45,100 sharesChange Vs. Previous Month-79.82%Dollar Volume Sold Short$106,288.00Short Interest Ratio0.1 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares1,809,660,000 sharesPercentage of Shares Shorted0.00%Today's Trading Volume326,908 sharesAverage Trading Volume232,249 sharesToday's Volume Vs. Average141% Short Selling Astellas Pharma? Sign up to receive the latest short interest report for Astellas Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartALPMY Short Interest Over TimeALPMY Days to Cover Over TimeALPMY Percentage of Float Shorted Over Time Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Astellas Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/20249,100 shares $106,288.00 -79.8%N/A0.1 $11.68 10/15/202445,100 shares $517,297.00 +16.2%N/A0.2 $11.47 9/30/202438,800 shares $444,260.00 +269.5%N/A0.3 $11.45 9/15/202410,500 shares $126,105.00 -75.4%N/A0.1 $12.01 8/31/202442,600 shares $528,666.00 +38.8%N/A0.3 $12.41 8/15/202430,700 shares $351,208.00 -89.7%N/A0.1 $11.44 Get the Latest News and Ratings for ALPMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Astellas Pharma and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024298,700 shares $3.47 million -11.9%N/A0.6 $11.61 7/15/2024338,900 shares $3.53 million +48.8%N/A1 $10.42 6/30/2024227,800 shares $2.25 million -10.5%N/A0.4 $9.86 6/15/2024254,500 shares $2.42 million +83.5%N/A0.3 $9.51 5/31/2024138,700 shares $1.36 million +87.2%N/A0.2 $9.81 5/15/202474,100 shares $726,180.00 -11.7%N/A0.1 $9.80 4/30/202483,900 shares $801,245.00 +20.2%N/A0.1 $9.55 4/15/202469,800 shares $647,150.70 -59.4%N/A0.1 $9.27 3/31/2024171,800 shares $1.85 million +53.1%N/A0.3 $10.75 3/15/2024112,200 shares $1.21 million +51.6%N/A0.2 $10.83 2/29/202474,000 shares $808,820.00 +9.1%N/A0.2 $10.93 2/15/202467,800 shares $749,190.00 -19.7%N/A0.1 $11.05 1/15/202468,200 shares $823,856.00 -57.1%N/A0.2 $12.08 12/31/2023159,100 shares $1.89 million +305.9%N/A0.3 $11.90 12/15/202339,200 shares $445,312.00 -14.6%N/A0 $11.36 11/30/202345,900 shares $558,144.00 -7.8%N/A0.1 $12.16 11/15/202349,800 shares $579,921.00 +3.8%N/A0.1 $11.65 10/31/202348,000 shares $609,120.00 +1,197.3%N/A0.1 $12.69 10/15/20233,700 shares $48,248.00 -27.5%N/A0 $13.04 9/30/20235,100 shares $70,635.00 -54.1%N/A0 $13.85 9/15/202311,100 shares $165,501.00 -74.7%N/A0 $14.91 8/31/202343,900 shares $664,646.00 -43.9%N/A0.2 $15.14 8/15/202378,200 shares $1.18 million -38.0%N/A0.3 $15.13 7/31/2023126,200 shares $1.85 million +94.8%N/A0.3 $14.63 7/15/202364,800 shares $933,120.00 +9,157.1%N/A0.2 $14.40 6/30/2023700 shares $10,409.00 -98.3%N/A0 $14.87 6/15/202340,900 shares $659,308.00 -32.2%N/A0.5 $16.12 5/31/202360,300 shares $950,931.00 +61.2%N/A0.3 $15.77 5/15/202337,400 shares $599,522.00 +77.3%N/A0.4 $16.03 4/30/202321,100 shares $316,922.00 +64.8%N/A0.3 $15.02 4/15/202312,800 shares $189,568.00 -60.7%N/A0.1 $14.81 3/31/202332,600 shares $462,757.00 -26.4%N/A0.2 $14.20 3/15/202344,300 shares $610,011.00 -15.8%N/A0.2 $13.77 2/28/202352,600 shares $736,400.00 +310.9%N/A0.2 $14.00JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 2/15/202312,800 shares $183,936.00 +75.3%N/A0.1 $14.37 1/31/20237,300 shares $107,164.00 -73.7%N/A0 $14.68 1/15/202327,700 shares $404,974.00 -43.7%N/A0.2 $14.62 12/30/202249,200 shares $745,872.00 +278.5%N/A0.5 $15.16 12/15/202213,000 shares $202,410.00 -75.8%N/A0.2 $15.57 11/30/202253,600 shares $828,656.00 -48.9%N/A0.5 $15.46 11/15/2022104,900 shares $1.58 million +88.3%N/A0.4 $15.07 10/31/202255,700 shares $772,002.00 -50.2%N/A0.2 $13.86 10/15/2022111,900 shares $1.49 million +5.3%N/A0.3 $13.33 9/30/2022106,300 shares $1.42 million +544.2%N/A0.2 $13.33 9/15/202216,500 shares $227,205.00 No ChangeN/A0 $13.77 8/15/20222,000 shares $30,600.00 -95.6%N/A0 $15.30 7/31/202245,100 shares $702,207.00 -32.5%N/A0.2 $15.57 7/15/202266,800 shares $1.06 million -63.5%N/A0.5 $15.82 6/30/2022183,100 shares $2.85 million +367.1%N/A0.8 $15.56 6/15/202239,200 shares $587,216.00 +1,087.9%N/A0.2 $14.98 5/31/20223,300 shares $52,503.00 -85.3%N/A0 $15.91 5/15/202222,400 shares $339,360.00 -62.5%N/A0.1 $15.15 4/30/202259,700 shares $905,649.00 +69.1%N/A0.3 $15.17 4/15/202235,300 shares $580,685.00 +451.6%N/A0.2 $16.45 3/31/20226,400 shares $99,712.00 +220.0%N/A0 $15.58 3/15/20222,000 shares $31,320.00 -75.3%N/A0 $15.66 2/28/20228,100 shares $135,108.00 -77.7%N/A0 $16.68 2/15/202236,300 shares $627,046.20 -17.7%N/A0.2 $17.27 1/31/202244,100 shares $712,215.00 -4.8%N/A0.2 $16.15 1/15/202246,300 shares $764,413.00 +282.6%N/A0.3 $16.51 12/31/202112,100 shares $196,867.00 -55.4%N/A0.1 $16.27 12/15/202127,100 shares $431,161.00 -13.1%N/A0.1 $15.91 11/30/202131,200 shares $485,316.00 -50.9%N/A0.2 $15.56 11/15/202163,500 shares $1.10 million -54.7%N/A0.9 $17.37 10/29/2021140,300 shares $2.37 million +17.3%N/A1.5 $16.88 10/15/2021119,600 shares $2.10 million +65.2%N/A1.1 $17.55 9/30/202172,400 shares $1.20 million +95.7%N/A0.8 $16.52 9/15/202137,000 shares $629,000.00 +380.5%N/A0.4 $17.00 8/31/20217,700 shares $129,206.00 +3,750.0%N/A0.1 $16.78 8/13/2021200 shares $3,246.00 -97.2%N/A0 $16.23 7/30/20217,200 shares $114,624.00 -36.8%N/A0.1 $15.92 7/15/202111,400 shares $198,474.00 -81.7%N/A0.1 $17.41 6/30/202162,400 shares $1.08 million +20.9%N/A0.6 $17.38 6/15/202151,600 shares $904,548.00 -28.3%N/A0.3 $17.53 5/28/202172,000 shares $1.17 million +410.6%N/A0.8 $16.22 5/14/202114,100 shares $215,166.00 +1,914.3%N/A0.1 $15.26 4/30/2021700 shares $10,461.50 -82.1%N/A0 $14.95 4/15/20213,900 shares $58,812.00 -76.4%N/A0 $15.08 3/31/202116,500 shares $258,060.00 +66.7%N/A0.2 $15.64 3/15/20219,900 shares $164,835.00 -73.9%N/A0.1 $16.65 2/26/202137,900 shares $626,108.00 -41.4%N/A0.5 $16.52 2/12/202164,700 shares $1.10 million +462.6%N/A0.4 $16.99 1/29/202111,500 shares $188,370.00 -85.3%N/A0.1 $16.38 1/15/202140,400 shares $642,764.00 -34.0%N/A0.2 $15.91JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 12/31/202017,600 shares $271,040.00 -56.4%N/A0.1 $15.40 12/15/202040,400 shares $589,436.00 -34.0%N/A0.2 $14.59 11/30/202061,200 shares $954,108.00 +367.2%N/A0.5 $15.59 11/15/202013,100 shares $203,312.00 +718.8%N/A0.1 $15.52 10/30/20201,600 shares $22,256.00 -88.8%N/A0 $13.91 10/15/202014,300 shares $202,488.00 +44.4%N/A0.1 $14.16 9/30/20209,900 shares $147,609.00 +125.0%N/A0.1 $14.91 9/15/20204,400 shares $67,056.00 -91.3%N/A0 $15.24 8/31/202050,800 shares $796,036.00 +681.5%N/A0.4 $15.67 8/14/20206,500 shares $106,340.00 -59.4%N/A0.1 $16.36 7/31/202016,000 shares $251,168.00 +742.1%N/A0.1 $15.70 7/15/20201,900 shares $31,027.00 -96.6%N/A0 $16.33 6/30/202056,000 shares $932,960.00 +266.0%N/A0.6 $16.66 6/15/202015,300 shares $251,945.10 +393.6%N/A0.1 $16.47 5/29/20203,100 shares $55,304.00 -35.4%N/A0 $17.84 5/15/20204,800 shares $76,800.00 -66.0%N/A0.1 $16.00 4/30/202014,100 shares $230,535.00 +65.9%N/A0.1 $16.35 4/15/20208,500 shares $138,805.00 +7.6%N/A0.1 $16.33 3/31/20207,900 shares $129,165.00 -92.7%N/A0 $16.35 3/13/2020107,900 shares $1.67 million +233.0%N/A0.7 $15.52 2/28/202032,400 shares $427,032.00 -20.6%N/A0.4 $13.18 2/14/202040,800 shares $641,376.00 +164.9%N/A0.5 $15.72 1/31/202015,400 shares $249,172.00 -32.5%N/A0.3 $16.18 1/15/202022,800 shares $418,608.00 -30.3%N/A0.3 $18.36 12/31/201932,700 shares $569,307.00 +1,621.1%N/A0.5 $17.41 ALPMY Short Interest - Frequently Asked Questions What is Astellas Pharma's current short interest? Short interest is the volume of Astellas Pharma shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 9,100 shares of ALPMY short. Learn More on Astellas Pharma's current short interest. Is Astellas Pharma's short interest increasing or decreasing? Astellas Pharma saw a drop in short interest in October. As of October 31st, there was short interest totaling 9,100 shares, a drop of 79.8% from the previous total of 45,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Astellas Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Astellas Pharma: GSK plc (0.80%), Takeda Pharmaceutical Company Limited (0.19%), UCB SA (0.21%), Alnylam Pharmaceuticals, Inc. (2.87%), Merck KGaA (0.00%), Teva Pharmaceutical Industries Limited (1.60%), BeiGene, Ltd. (1.12%), Merck KGaA (0.22%), United Therapeutics Co. (5.24%), Viatris Inc. (2.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Astellas Pharma stock? Short selling ALPMY is an investing strategy that aims to generate trading profit from Astellas Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Astellas Pharma? A short squeeze for Astellas Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ALPMY, which in turn drives the price of the stock up even further. How often is Astellas Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ALPMY, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies GSK Short Interest TAK Short Interest UCBJF Short Interest ALNY Short Interest MKKGY Short Interest TEVA Short Interest BGNE Short Interest MKGAF Short Interest UTHR Short Interest VTRS Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:ALPMY) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astellas Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astellas Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALPMY Stock Alerts